Top broker slaps $7 price target on Orocobre Limited shares

The Orocobre Limited (ASX:ORE) share price could be on its way to $7.00 according to one leading broker…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Orocobre Limited (ASX: ORE) share price has continued its ascent on Monday and is higher by over 2.5% to $5.95 in early afternoon trade.

This means the lithium miner's shares have now climbed a remarkable 76% in just the last three months.

Can Orocobre's shares climb higher?

Although I feel that the shares of Orocobre are about fair value now, one leading broker disagrees and thinks they can still climb meaningfully higher from here.

According to a note out of UBS this morning, the broker has retained its buy rating and increased its price target on the lithium miner's shares to $7.00. This price target implies potential upside of approximately 18% from the current share price.

Last week Orocobre reaffirmed its full-year production guidance of 14,000 tonnes of lithium carbonate at its Olaroz site in Northern Argentina.

The broker, however, believes that management is being conservative and that there is the potential for stronger production this year.

Furthermore, the investment bank expects the lithium market to remain tight until at least 2020 due to rising demand for lithium carbonate from electric vehicle and renewable energy manufacturers.

This should ensure that lithium miners such as Orocobre, Galaxy Resources Limited (ASX: GXY), and Pilbara Minerals Ltd (ASX: PLS) continue to profit from sky high prices for the metal for some time to come.

Should you invest?

While I think that the lithium miners are all about fair value now and ought to be classed as holds, the price target set by UBS certainly provides a compelling risk/reward.

This could arguably make it a good investment option for investors with a high tolerance for risk and limited exposure to the lithium market.

Motley Fool contributor James Mickleboro owns shares of Galaxy Resources Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »